Anika Therapeutics Newsroom

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow JonesNov 1 23:23

Anika Therapeutics Analyst Ratings

BenzingaNov 1 23:14

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 1 22:31

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Maintains Target Price $37

Futu NewsOct 22 21:34

Analysts Are Bullish on Top Healthcare Stocks: Chromadex (CDXC), Anika Therapeutics (ANIK)

TipRanksOct 22 21:27

Anika Therapeutics Analyst Ratings

BenzingaAug 10 05:45

Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $37 Price Target

BenzingaAug 10 05:45

Buy Rating Affirmed for Anika Therapeutics Amid Solid Financials and Strong Market Outlook

TipRanksAug 9 21:39

Anika Therapeutics Analyst Ratings

BenzingaMay 29 21:25

Barrington Research: Maintaining the Anika Therapeutics (ANIK.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $37.00 to $37.00.

Zhitong FinanceMay 10 00:20

Anika Therapeutics Analyst Ratings

BenzingaMay 10 00:20

Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Anika Therapeutics (ANIK)

TipRanksMay 9 23:15

Anika Therapeutics: Strong Q4 Performance and Upbeat FY2024 Outlook Justify Buy Rating and Raised Price Target

TipRanksMar 14 22:20

Anika Therapeutics Analyst Ratings

BenzingaMar 14 21:55

Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $29

BenzingaJan 3 23:12

Anika Therapeutics Analyst Ratings

BenzingaJan 3 23:10

Anika Therapeutics Receives Buy Rating Based on Strong Q3 Performance and Positive 2023 Outlook

TipRanksNov 3, 2023 21:16

Anika Therapeutics (ANIK) Receives a Buy From Barrington

TipRanksSep 21, 2023 23:22

Anika Therapeutics Analyst Ratings

BenzingaAug 14, 2023 20:44

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

BenzingaAug 10, 2023 22:16